Kestra Medical Technologies, Ltd.
KMTSNASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $1.68B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $17.34$30.00
- Volume (live)
- -
- Avg. volume (3M)
- 443.86K
Kestra Medical Technologies (KMTS) Stock Price & Financial Analysis
Kestra Medical Technologies Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $27.96 - $28.93 |
|---|---|
| 52-Week High | $30.00 |
| 52-Week Low | $17.34 |
| Open | $28.09 |
| Volume (last close) | 357.21K |
| Average Volume (3M) | 443.86K |
| Revenue (TTM) | 106.73M |
|---|---|
| Net Income (TTM) | -149.87M |
| Free Cash Flow (TTM) | -122.97M |
| EPS (TTM) | −$2.67 |
| Profit Margin | -140.43% |
| Operating Margin | -134.48% |
| Return on Equity (ROE) | -67.40% |
| Debt to Equity | 0.34 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.68B |
|---|---|
| Shares Outstanding | 58.57M |
| Price to Sales (P/S) | 15.78 |
| Price to Book (P/B) | 7.58 |
| EV/EBITDA | -12.91 |
| 50-Day MA | $26.46 |
|---|---|
| 200-Day MA | $23.62 |
| 1-Year Change | +10.24% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Kestra Medical Technologies at a Glance
As of the Oct 23, 2026 close, Kestra Medical Technologies (KMTS) has a market capitalization of $1.68B. The stock trades at 15.8× sales. Over the trailing twelve months it lost $149.87M on revenue of $106.73M and burned $122.97M of free cash flow. Revenue grew 60.7% year over year.
As of its latest reported balance sheet, it holds $68.56M in cash and securities against $76.45M of debt, a net debt position of $7.89M.
Kestra Medical Technologies does not currently pay a dividend.
The share price is up 10.2% over the past year. At $28.76 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $17.34 to $30.00, above its 200-day moving average of $23.62.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $30.00, 4.3% above the Oct 23, 2026 close.
Frequently Asked Questions About Kestra Medical Technologies
What is the current stock price for KMTS?
As of the Oct 23, 2026 close, KMTS stock trades at $28.76. The 52-week range is $17.34–$30.00, with a day range of $27.96–$28.93.
What is the P/E ratio for KMTS?
The P/E ratio (Price-to-Earnings) for KMTS is shown in the Key Statistics section. This valuation metric helps compare Kestra Medical Technologies, Ltd. to industry peers.
Does KMTS pay dividends?
Kestra Medical Technologies does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for KMTS?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for KMTS is Buy. The average 12-month price target is $30.00, a 4.3% upside from the Oct 23, 2026 close of $28.76.
What is the market cap of KMTS?
As of the Oct 23, 2026 close, Kestra Medical Technologies's market capitalization is $1.68B, classifying it as a small-cap company. Kestra Medical Technologies operates in the Healthcare sector within the Medical Instruments & Supplies industry.